RxDoctor Payments Data

Courtney Freeman, APRN

Nurse Practitioner · Greensboro, NCNPI 1235778317

Payments from drug & device makers

$2,327in general payments, 2019–2025

Across 121 payments — averaging $19.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$475
  • Ardelyx, Inc.$342
  • AbbVie$333
  • Aimmune Therapeutics, Inc.$237
  • Takeda Pharmaceuticals U.S.A., Inc.$175
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$159
  • plus $607 from 14 others

What the payments were for

  • Food & beverage$2,327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,327 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$66,350
Medicare patients
187
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban159$94,335
CreonLipase/Protease/Amylase25$46,501
JanuviaSitagliptin Phosphate41$23,612
XareltoRivaroxaban39$21,804
JardianceEmpagliflozin35$19,981
MyrbetriqMirabegron24$11,015
EntrestoSacubitril/Valsartan17$10,991
LinzessLinaclotide16$10,237
NeuproRotigotine11$9,838
Levothyroxine Sodium520$8,119
RestasisCyclosporine12$7,890
GemtesaVibegron13$6,287
Incruse ElliptaUmeclidinium Bromide16$6,051
Atorvastatin Calcium286$5,001
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc50$4,972

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$77$94,335159 claims
AbbVieCreon, Linzess, Restasis, Lumigan$333$67,86565 claims
MerckJanuvia$35$23,61241 claims
Johnson & JohnsonXarelto$475$21,80439 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →